NWBO closes Advent BioServices acquisition; pays £1.4M + AP over 2 years; 19M securities revert

NORTHWEST BIOTHERAPEUTICS INC

Acquisition of Advent BioServices closed; Advent becomes wholly owned subsidiary.
No new shares issued; 13.5M shares and 5.5M options previously issued to Advent revert to NWBO.
Consideration: £1.4 million plus net accounts payable, paid in installments over two years starting 90 days post-closing.
Installment payments may accelerate upon regulatory approval of DCVax-L; NWBO receives fixed assets, cryostorage, and IP.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.